The Scarborough General Hospital is a major hospital in the Scarborough district of Toronto, Ontario, Canada. Located northwest of the intersection of McCowan Road and Lawrence Avenue East, the hospital opened in 1956 as the first in the former township of Scarborough.

There are 556 beds in Scarborough General Hospital.

During the past decade, Scarborough General Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Scarborough General Hospital" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Cancer Research UK" with 2 trials sponsored, "Institute of Cancer Research, United Kingdom" with 2 trials sponsored, "Medical Research Council" with 2 trials sponsored and "Scarborough General Hospital" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Scarborough General Hospital" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Medical Research Council" with 1 trials as a collaborator, "Norgine" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Scarborough General Hospital" are "Prostate Cancer" (5 trials), "Breast Cancer" (4 trials), "Colorectal Cancer" (4 trials), "Lung Cancer" (2 trials) and "Metastatic Cancer" (2 trials). Many other conditions were trialed in "Scarborough General Hospital" in a lesser frequency.

Most popular intervention types in "Scarborough General Hospital" are "Drug" (21 trials), "Procedure" (8 trials), "Other" (6 trials), "Radiation" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (4 trials), "quality-of-life assessment" (4 trials), "adjuvant therapy" (3 trials), "cetuximab" (2 trials) and "cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Scarborough General Hospital" are 21 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Scarborough General Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Scarborough General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Scarborough General Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".